Journal Club: Using CRISPR to Prevent Coronavirus and Influenza Infection
The a16z Show15 Mai 2020

Journal Club: Using CRISPR to Prevent Coronavirus and Influenza Infection

In this episode of a16z bio Journal Club, general partner Vijay Pande, bio deal team partner Andy Tran, and bio editor Lauren Richardson discuss a novel CRISPR-Cas-based anti-viral strategy.

The discussion covers the differences between this newly developed prophylactic strategy, traditional vaccines, and anti-viral drugs; how this strategy can be engineered to target a huge range of coronavirus and influenza strains; and the next steps needed to go from paper to practice:

a16z Journal Club (part of the a16z Podcast), curates and covers recent advances from the scientific literature -- what papers we’re reading, and why they matter from our perspective at the intersection of biology & technology (for bio journal club). You can find all these episodes at a16z.com/journalclub.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(1000)

a16z Podcast: Network Effects, Origin Stories, and the Evolution of Tech

a16z Podcast: Network Effects, Origin Stories, and the Evolution of Tech

“The rules of the game are different in tech,” argues — and has long argued, despite his views not being accepted at first — W. Brian Arthur, technologist-turned-economist who first truly described th...

17 Mai 20181h 5min

a16z Podcast: The Oral History Of TrialPay — Obstacles and Opportunities in Payments

a16z Podcast: The Oral History Of TrialPay — Obstacles and Opportunities in Payments

In this hallway-style conversation (originally recorded as a video), a16z general partner Alex Rampell and Terry Angelos, SVP of Commerce Solutions at Visa, discuss the trials and tribulations of thei...

10 Mai 201846min

a16z Podcast: Shifting Risk Mindsets, From Tech to Bio

a16z Podcast: Shifting Risk Mindsets, From Tech to Bio

What challenges do first-time founders or tech founders encounter when building companies in the bio space, and how do they differ from traditional tech companies? In this hallway-style conversation e...

10 Mai 201827min

a16z Podcast: The Case Against Education, From Signaling to Rainbow's End

a16z Podcast: The Case Against Education, From Signaling to Rainbow's End

with Bryan Caplan (@bryan_caplan), Marc Andreessen (@pmarca), and Sonal Chokshi (@smc90) Signaling and credential inflation -- not learning -- can explain why education pays in the labor market, and w...

9 Mai 201844min

a16z Podcast: Breaking Into Bio

a16z Podcast: Breaking Into Bio

with Atul Butte (@atulbutte), Daphne Koller (@daphnekoller), and Vijay Pande (@vijaypande) Whether you’re an academic seeking to move out of research and into industry, or simply interested in working...

2 Mai 201841min

a16z Podcast: Principles and Algorithms for Work and Life

a16z Podcast: Principles and Algorithms for Work and Life

with Ray Dalio (@raydalio), Alex Rampell (@arampell), and Sonal Chokshi (@smc90) Can one really apply the lessons of history and of the past to the present and the future, as a way to get what they wa...

21 Apr 201849min

a16z Podcast: On Recent Consolidation in the Healthcare Industry

a16z Podcast: On Recent Consolidation in the Healthcare Industry

Many of the healthcare headlines lately have been about consolidation in the industry: Walmart and Humana; Aetna and CVS; Amazon, JP Morgan, and Berkshire Hathaway. But what does it all mean for patie...

16 Apr 20188min

a16z Podcast: Players and Paths for Healthcare Startups

a16z Podcast: Players and Paths for Healthcare Startups

The creation of each new biotechnology enables a tool, a therapy, or a diagnostic: a molecule, a protein, an app, a platform. And the process underneath isn't just complex in the science and engineeri...

16 Apr 20187min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengepodden-2
pengesnakk
utbytte
rss-politisk-preik
finansredaksjonen
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
livet-pa-veien-med-jan-erik-larssen
stormkast-med-valebrokk-stordalen
rss-markedspuls-2
rss-pa-konto
rss-sunn-okonomi
lederpodden
rss-investering-gjort-enkelt